Chris A. Rallis

CIK: 0001185945

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (43.8%)

Position reduction

Option Exercises (M)7 (43.8%)

Derivative conversions

Awards (A)2 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENC

FENNEC PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

FENC
FENNEC PHARMACEUTICALS INC.
Jun 10, 2026
Award(A)
Stock Option
Direct
20K shares at avg. $8.70-
FENC
FENNEC PHARMACEUTICALS INC.
May 11, 2026
Exercise(M)
Direct
14.3K shares at avg. $2.44$35K
FENC
FENNEC PHARMACEUTICALS INC.
May 11, 2026
Sale(S)
Direct
8.3K shares at avg. $7.04$59K
FENC
FENNEC PHARMACEUTICALS INC.
Oct 10, 2025
Exercise(M)
Direct
4.1K shares at avg. $1.23$5K
FENC
FENNEC PHARMACEUTICALS INC.
Oct 10, 2025
Sale(S)
Direct
1.8K shares at avg. $9.24$16K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 7, 2025
Exercise(M)
Direct
2.1K shares at avg. $2.35$5K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 7, 2025
Sale(S)
Direct
1.1K shares at avg. $8.71$10K
FENC
FENNEC PHARMACEUTICALS INC.
Jun 3, 2025
Award(A)
Stock Option
Direct
20K shares at avg. $7.88-
FENC
FENNEC PHARMACEUTICALS INC.
Apr 11, 2025
Sale(S)
Direct
1.4K shares at avg. $4.95$7K
FENC
FENNEC PHARMACEUTICALS INC.
Apr 11, 2025
Exercise(M)
Direct
2.2K shares at avg. $2.30$5K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 14, 2025
Sale(S)
Direct
1.2K shares at avg. $6.82$8K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 14, 2025
Exercise(M)
Direct
2K shares at avg. $2.51$5K
FENC
FENNEC PHARMACEUTICALS INC.
Dec 2, 2024
Exercise(M)
Direct
10K shares at avg. $2.69$27K
FENC
FENNEC PHARMACEUTICALS INC.
Dec 2, 2024
Sale(S)
Direct
6.4K shares at avg. $6.14$39K
FENC
FENNEC PHARMACEUTICALS INC.
Oct 8, 2024
Exercise(M)
Direct
2K shares at avg. $2.55$5K
FENC
FENNEC PHARMACEUTICALS INC.
Oct 8, 2024
Sale(S)
Direct
1.4K shares at avg. $4.53$6K

		Type	Shares	Price		Ownership
Jun 10, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Option	20,000	$8.70	-	Direct
May 11, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	14,344	$2.44	$34,999	Direct
May 11, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	8,346	$7.04	$58,756	Direct
Oct 10, 2025	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	4,062	$1.23	$4,996	Direct
Oct 10, 2025	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	1,775	$9.24	$16,401	Direct
Jul 7, 2025	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	2,127	$2.35	$4,998	Direct
Jul 7, 2025	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	1,119	$8.71	$9,746	Direct
Jun 3, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Option	20,000	$7.88	-	Direct
Apr 11, 2025	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	1,409	$4.95	$6,975	Direct
Apr 11, 2025	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	2,173	$2.30	$4,998	Direct
Feb 14, 2025	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	1,186	$6.82	$8,089	Direct
Feb 14, 2025	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	1,992	$2.51	$5,000	Direct
Dec 2, 2024	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	10,000	$2.69	$26,900	Direct
Dec 2, 2024	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	6,409	$6.14	$39,351	Direct
Oct 8, 2024	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	1,960	$2.55	$4,998	Direct
Oct 8, 2024	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	1,406	$4.53	$6,369	Direct

1-16 of 16 transactions

About RALLIS CHRIS A

RALLIS CHRIS A (SEC CIK 0001185945) files insider reports with the SEC as Director of FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 9 ownership filings by RALLIS CHRIS A, all Form 4s, filed between Oct 10, 2024 and Jun 10, 2026. Those filings report 16 transactions, from Oct 8, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on RALLIS CHRIS A's filings is in RESEARCH TRIANGLE PARK, NC.

Recent filings by RALLIS CHRIS A

Jun 10, 2026: Grant or award of FENC derivative securities (Form 4, code A).
May 11, 2026: Option exercise of FENC shares (Form 4, code M).
May 11, 2026: Open-market sale of FENC shares (Form 4, code S).
Oct 10, 2025: Option exercise of FENC shares (Form 4, code M).
Oct 10, 2025: Open-market sale of FENC shares (Form 4, code S).

Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)

Evans Terry L, Chief Commercial Officer
Sayad Pierre Sargis, Chief Medical Officer
Hackman Jeffrey S., Chief Executive Officer
Cioffi Christiana Marie, Chief Strategy Officer
Andrade Robert, CHIEF FINANCIAL OFFICER
Brughera Marco Maria, Director

How to read Form 4 transaction codes